Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zoë J. Konn
Observed names:
Z J Konn,
Z Konn,
Z. Konn,
Zoe J Konn,
Zoe J. Konn,
Zoe Konn,
Zoë Konn
show all 7
Institutions:
University Hospital Southampton NHS Foundation Trust,
University of Southampton
Observed institutions:
University of Leeds,
Institute of Cancer Research,
Salisbury District Hospital,
Royal Victoria Infirmary,
Cancer Research UK,
University Hospital Southampton NHS Foundation Trust,
Wessex Regional Genetics Laboratory,
University of Southampton,
Newcastle University
show all 9
ORCID:
0009-0004-1672-5011
Observed ORCID:
0009-0004-1672-5011
OpenAlex ID:
A5015337693
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value
2010
·
Brian A. Walker
, Paola E. Leone
, et al.
·
Blood
·
399
PDF
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
2011
·
K D Boyd
, F M Ross
, et al.
·
Leukemia
·
362
A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups
2008
·
Sarina Sulong
, Anthony V. Moorman
, et al.
·
Blood
·
245
Mapping of Chromosome 1p Deletions in Myeloma Identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as Being Genes in Regions Associated with Adverse Survival
2011
·
Kevin D. Boyd
, Fiona M. Ross
, et al.
·
Clinical Cancer Research
·
203
Variable breakpoints target PAX5 in patients with dicentric chromosomes: A model for the basis of unbalanced translocations in cancer
2008
·
Qian An
, Sarah L. Wright
, et al.
·
Proceedings of the National Academy of Sciences
·
94
The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide‐based therapy
2011
·
Kevin D. Boyd
, Fiona M. Ross
, et al.
·
Genes Chromosomes and Cancer
·
72
The complex genomic profile of ETV6‐RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1
2008
·
Helen Parker
, Qian An
, et al.
·
Genes Chromosomes and Cancer
·
68
Gender Disparities in the Tumor Genetics and Clinical Outcome of Multiple Myeloma
2011
·
Kevin D. Boyd
, Fiona M. Ross
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
·
65
Long-term follow-up of ETV6–RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor
2013
·
A Enshaei
, C J Schwab
, et al.
·
Leukemia
·
27
Abnormalities of the der(12)t(12;21) in ETV6‐RUNX1 acute lymphoblastic leukemia
2012
·
Halima Al‐Shehhi
, Zoe J. Konn
, et al.
·
Genes Chromosomes and Cancer
·
25
Disruption of ETV6 in intron 2 results in upregulatory and insertional events in childhood acute lymphoblastic leukaemia
2007
·
G R Jalali
, Q An
, et al.
·
Leukemia
·
17
Heterogeneity in the Prognostic Significance of 12p Deletion and Chromosome 5 Amplification in Multiple Myeloma
2010
·
William Tapper
, Laura Chiecchio
, et al.
·
Journal of Clinical Oncology
·
13
PDF
Variable Breakpoints Target PAX5 in Patients with Dicentric Chromosomes: A Model for the Basis of Unbalanced Translocations in Cancer
2008
·
Jonathan C Strefford
, Qian An
, et al.
·
Blood
·
13
Gain of 1q21 Does Not Predict for Immediate Progression in MGUS.
2009
·
Laura Chiecchio
, Gian Paolo Dagrada
, et al.
·
Blood
·
8
Cytogenetics of long‐term survivors of ETV6‐RUNX1 fusion positive acute lymphoblastic leukemia
2009
·
Zoë J. Konn
, Mary Martineau
, et al.
·
Genes Chromosomes and Cancer
·
7
Fluorescence In Situ Hybridization (FISH) as a Tool for the Detection of Significant Chromosomal Abnormalities in Childhood Leukaemia
2009
·
Zoë J. Konn
, Sarah L. Wright
, et al.
·
Methods in molecular biology
·
7
Haploinsufficiency of the MLL and TOB2 genes in lymphoid malignancy
2009
·
Q An
, G A A Burke
, et al.
·
Leukemia
·
4
Abstract CT263: Efficacy and multiomic analysis of Niraparib in relapsed mesothelioma: NERO a randomized phase II trial
2025
·
Dean Fennell
, Kayleigh Hill
, et al.
·
Cancer Research
·
3
The Spectrum and Prognostic Relevance of Additional Abnormalities, Involving 12p and 21q, in Children with ETV6-RUNX1 Positive Acute Lymphoblastic Leukaemia (ALL)
2008
·
Anthony V Moorman
, Zoe J Konn
, et al.
·
Blood
·
3
Clinical and Biological Effects of Combined CD27 and CD20 Antibody Therapy in Relapsed/Refractory B-Cell Lymphoma: The Riva Trial
2021
·
Sean H Lim
, Heng Sheng Sow
, et al.
·
Blood
·
2
Defining High Risk Myeloma Using Co-Segregating FISH Variables; Results of MRC Myeloma IX
2010
·
Kevin D Boyd
, Fiona M. Ross
, et al.
·
Blood
·
2
CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial
2025
·
Lara E. Buermann
, Louise Stanton
, et al.
·
Clinical Cancer Research
·
1
Data from CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial
2025
·
Lara E. Buermann
, Louise Stanton
, et al.
Supplementary Figure S10 from CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial
2025
·
Lara E. Buermann
, Louise Stanton
, et al.
Supplementary Figure S1 from CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial
2025
·
Lara E. Buermann
, Louise Stanton
, et al.
Show more works
View as search
Works count:
64
Citation count:
1,640
H-index:
13
I10-index:
13
Year
Topic
Type